The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans
Abstract
Methodology for measuring plasma free fatty acid (FFA) turnover/oxidation with [1-14C]palmitate was tested in normal subjects. In study 1, two different approaches (720-min tracer infusion without prime vs. 150-min infusion with NaH14CO3 prime) to achieve steady-state conditions of 14CO2 yielded equivalent rates of plasma FFA turnover/oxidation. In study 2, during staircase NaH14CO3 infusion, calculated rates of 14CO2 appearance agreed closely with NaH14CO3 infusion rates. In study 3, 300-min euglycemic insulin clamp documented that full biological effect of insulin on plasma FFA turnover/oxidation was established within 60-120 min. In study 4, plasma insulin concentration was raised to 14 +/- 2, 23 +/- 2, 38 +/- 2, 72 +/- 5, and 215 +/- 10 microU/ml. A dose-dependent insulin suppression of plasma FFA turnover/oxidation was observed. Plasma FFA concentration correlated positively with plasma FFA turnover/oxidation in basal and insulinized states. Total lipid oxidation (indirect calorimetry) was significantly higher than plasma FFA oxidation in the basal state, suggesting that intracellular lipid stores contributed to whole body lipid oxidation. Hepatic glucose production and total glucose disposal showed the expected dose-dependent suppression and stimulation, respectively, by insulin. In conclusion, insulin regulation of plasma FFA turnover/oxidation is maximally manifest at low physiological plasma insulin concentrations, and in the basal state a significant contribution to…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As lipolysis is more sensitive to small changes in insulin concentration than EGP [35, 36], and plasma NEFA levels are closely correlated with changes in lipolysis”
From Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial (2011) · cites this paper as [35]
Citations
Cites
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationMandarino, L. J., Wright, K. S., Verity, L. S., Nichols, J., Bell, J. M., Kolterman, O. G., & Beck-Nielsen, H. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113118 · Cited by 194
Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
Lillioja, S., Bogardus, C., Mott, D. M., Kennedy, A. L., Knowler, W. C., & Howard, B. V. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111804 · Cited by 150
Hagenfeldt, L., & Wahren, J. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076994 · Cited by 138
Research works printed but not linked: 42
- ABIJMRAD N. A., 1986, J. Biol. Chem., 261, 2999, 10.1016/S0021-9258(17)35735-6 · DOI
- ARMSTRONG D. T., 1961, Am. J. Physiol., 201, 9, 10.1152/ajplegacy.1961.201.1.9 · DOI
- 10.1016/0026-0495(81)90020-2 · DOI
- BARTER P. J., 1972, J. Lipid Res., 113, 483, 10.1016/S0022-2275(20)39382-2 · DOI
- 10.1016/0026-0495(83)90137-3 · DOI
- 10.2337/diabetes.34.9.884 · DOI
- 10.1210/jcem-67-5-893 · DOI
- 10.1172/JCI113272 · DOI
- COBELLI C., A., 1987, Metab. 15), E679
- COMMISSION OF THE ICRP, 1977, Ann. ICRP, 1, 21
- 10.1172/JCI113206 · DOI
- DARMAUN D., D., 1986, Metab. 14), E117
- 10.2337/diab.32.1.35 · DOI
- 10.1016/0026-0495(88)90110-2 · DOI
- 10.2337/diab.36.8.914 · DOI
- 10.2337/diab.37.8.1025 · DOI · Paper page
- FOLEY J. E., 1986, Metab. 14), E306
- HAGENFELDT L, 1975, Federation Proc., 34, 2246
- 10.1172/JCI107043 · DOI
- HALES C. N., 1978, Biochem. Sot. Symp., 43, 97
- HELLMAN L., W., 1953, Medical and Physiological Applications. London: Her Majesty's Stationary Office, 1, 299
- 10.1152/physrev.1983.63.2.606 · DOI
- 10.1016/0026-0495(87)90096-5 · DOI
- IRVING C. S., 1983, Physiol. 14), R190
- 10.1016/S0026-0495(68)80008-3 · DOI
- 10.1172/JCI112137 · DOI
- MILES J., R., 1983, J. Lipid Res., 24, 96, 10.1016/S0022-2275(20)38029-9 · DOI
- MILES J. M., 1987, Metab. 15), E431
- 10.2337/diab.28.12.1039 · DOI · Paper page
- 10.1016/0026-0495(78)90025-2 · DOI
- 10.1139/y73-012 · DOI
- 10.2337/diab.35.12.1326 · DOI
- PAUL P., B., 1966, Am. J. Physiol., 211, 1313, 10.1152/ajplegacy.1966.211.6.1313 · DOI
- 10.1016/S0140-6736(63)91500-9 · DOI · Paper page
- 10.1097/00000658-198704000-00005 · DOI
- SWISLOCKI A. L., 1987, Diabetologia, 30, 622, 10.1007/BF00277318 · DOI
- THIEBAUD D., E., 1982, Diabetologia, 31, 957
- WATERHOUSE C., N., 1969, J. Lipid Res., 110, 487, 10.1016/S0022-2275(20)43039-1 · DOI
- 10.1073/pnas.56.1.247 · DOI
- WOLFE R. R., 1985, J. Lipid Res., 26, 210, 10.1016/S0022-2275(20)34391-1 · DOI
- 10.1002/bms.1200070407 · DOI
- 10.1172/JCI113011 · DOI
Cited by
Sorted by citations
Items 101–141 of 141
The Thrifty Phenotype Hypothesis: How Does it Look After 5 Years?
Hales, C. N., Desai, M., & Ozanne, S. E. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199703)14:3 · Cited by 88
Saravanan, R., & Pari, L. (2006) · Journal of Biosciences · doi:10.1007/bf02708410 · Cited by 16
“Serum-FFA concentration are a result of the balance between the release from lipolysis, neosynthesis and disposal and represent the major determinant of insulin effect on free fatty acid oxidation and non-oxidative metabolism (Bonadonna et al 1990).”
BackgroundImpact of acute epinephrine removal on hepatic glucose metabolism during stress hormone infusion.
McGuinness, O. P., Snowden, R. T., Moran, C., Neal, D., Fujiwara, T., & Cherrington, A. (1999) · Metabolism: Clinical and Experimental · doi:10.1016/s0026-0495(99)90228-7 · Cited by 19
Koška, J., Ortega, E., Bogardus, C., Krakoff, J. A., & Bunt, J. C. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00662.2006 · Cited by 13
Monti, L. D., Brambilla, P., Stefani, I., Caumo, A., Magni, F., Poma, R., Tomasini, L., Agostini, G., Galli-Kienle, M., Cobelli, C., et al. (1995) · Diabetologia · doi:10.1007/bf00401849 · Cited by 24
“Nevertheless, since in obese children NEFA levels during the clamp remained higher than in control children and it has been extensively demonstrated that NEFA oxidation correlates with plasma NEFA concentration [54-56], we speculate that NEFA oxidation may be increased in obese children, which might contribute to insu…”
Vuorinen-Markkola, H., Yki-Järvinen, H., & Taskinen, M. (1993) · Diabetologia · doi:10.1007/bf00400699 · Cited by 18
“To determine the rate of plasma NEFA oxidation during the [1 14C]palmitate infusion, the specific activity of expired air CO2 was measured as depicted in Figure I and as previously described [24, 29, 30].”
MethodKumar, M., Sharma, S., & Vasudeva, N. (2013) · Advanced Pharmaceutical Bulletin · doi:10.5681/apb.2013.058 · Cited by 17
Chen, X., Ruiz, J., & Boden, G. H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90080-2 · Cited by 16
Habitual fat intake and basal fat oxidation in obese and non-obese Caucasians
Kunz, I., Schorr, U., Römmling, K., Klaus, S., & Am, S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801869 · Cited by 16
Energy expenditure and substrate metabolism after oral fructose in patients with cirrhosis.
Kruszynska, Y., Meyer-Alber, A., Wollen, N., & McIntyre, N. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80578-1 · Cited by 14
Chandramohan, G., Al-Numair, K., Sridevi, M., & Pugalendi, K. (2010) · Journal of biochemical and molecular toxicology · doi:10.1002/jbt.20317 · Cited by 13
“Plasma and tissue FFA concentrations are a result of the balance between the release from lipolysis, neosynthesis, and disposal and represent the major determinant of insulin effect on free fatty acid oxidation and nonoxidative metabolism [30].”
BackgroundInsulin Resistance in High Fat Fed Rats
Fryer, L. G. D., & Kruszynska, Y. T. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35695.x · Cited by 13
Lipid metabolism and insulin resistance in cirrhosis
Kaye, G., Kruszynska, Y. T., Harry, D. S., Heslop, K. E., Johnston, D. G., & McIntyre, N. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80150-3 · Cited by 14
Insulin regulation of regional lipolysis in upper-body obese and lean humans
Nielsen, S., & Jensen, M. D. (2024) · JCI Insight · doi:10.1172/jci.insight.175629 · Cited by 15
“Specifically, and impaired ability of insulin to suppress adipose tissue lipolysis (3) and hepatic glucose and triglyceride secretion (4) and to promote glucose disposal in peripheral tissues has been well described.”
BackgroundMaximizing Acute Fat Utilization: Effects of Exercise, Food, and Individual Characteristics
Bennard, P., Imbeault, P., & Doucet, É. (2005) · Canadian Journal of Applied Physiology · doi:10.1139/h05-134 · Cited by 9
The use of stable isotopes and mass spectrometry in studying lipid metabolism
Beylot, M. (1994) · Proceedings of The Nutrition Society · doi:10.1079/pns19940041 · Cited by 11
“Second, isotopic estimates of plasma FFA oxidation in the postabsorptive state are much lower (usually one-third to half) than estimates of lipid oxidation determined by indirect calorimetry (Bonadonna et al. 1990; Groop et al. 1991).”
BackgroundRobertson, D. A., Singh, B. M., Hale, P. J., & Nattrass, M. (1992) · Metabolism · doi:10.1016/0026-0495(92)90052-c · Cited by 11
Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning
Nielsen, M. F., Dinneen, S. F., Basu, A., Basu, R., Alzaid, A., & Rizza, R. (1998) · Diabetologia · doi:10.1007/s001250051031 · Cited by 11
“Since plasma non-esterified fatty acid concentration and turnover are closely linked [48, 49], the lower concentrations after overnight growth hormone deficiency implies lower rates of lipolysis.”
BackgroundMethods to Assess In Vivo Insulin Sensitivity and Insulin Secretion
Bonadonna, R. C., Boselli, L., Dei, A., & Trombetta, M. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_11-1 · Cited by 8
Self-citationBeta-Cell Dysfunction and Insulin Resistance after Subarachnoid Haemorrhage
Kruyt, N., Musters, A., Biessels, G., DeVries, J., Coert, B., Vergouwen, M., Horn, J., & Roos, Y. B. (2011) · Neuroendocrinology · doi:10.1159/000324097 · Cited by 10
Muscle Type‐Dependent Responses to Insulin in Intramyocellular Triglyceride Turnover in Obese Rats
Guo, Z., & Zhou, L. (2005) · Obesity Research · doi:10.1038/oby.2005.258 · Cited by 9
Thomaseth, K., Brehm, A., Pavan, A., Pacini, G., & Roden, M. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00314.2013 · Cited by 9
“These differ mainly in the mathematical description of the factors regulating the rate of NEFA appearance; in particular, the control mechanisms for lipolysis have been described in terms of 1) insulin-action alone (14, 22), which is in line with current knowledge on antilipolytic effects of insulin even at basal gluc…”
BackgroundHummel, J., Fritsche, L., Vosseler, A., Dannecker, C., Hoene, M., Kantartzis, K., Häring, H., Stefan, N., Machann, J., Birkenfeld, A. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95750-9 · Cited by 10
Snitker, S., Hellmér, J., Boschmann, M., Monroe, M. B., & Ravussin, É. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.3.e400 · Cited by 5
Macdougall, D., Jones, P., Kitts, D., & Phang, P. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.6.918 · Cited by 7
Bernstein, M. J., Jahoor, F., Townsend, C., & Klein, S. (2001) · Metabolism: Clinical and Experimental · doi:10.1053/meta.2001.23306 · Cited by 6
Lipid metabolism and substrate oxidation during intravenous fructose administration in cirrhosis.
Kruszynska, Y., Harry, D. S., Fryer, L., & McIntyre, N. (1994) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(94)90062-0 · Cited by 6
The Role of the Liver in Insulin Action and Resistance
Radziuk, J., & Pye, S. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_11 · Cited by 5
Rossi, R., Meissner, A., Prete, E. D., & Scharrer, E. (1996) · Experimental Physiology · doi:10.1113/expphysiol.1996.sp003913 · Cited by 6
LIPOLYTIC SUPPRESSION FOLLOWING CARBOHYDRATE INGESTION LIMITS FAT OXIDATION DURING EXERCISE 442
Horowitz, J. F., Mora-Rodríguez, R., Byerley, L., & Coyle, E. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199605001-00443 · Cited by 5
“, 10–30 μU/ml) dramatically reduce lipolysis at rest (4, 5), yet lipolysis still appears to be in excess of fat oxidation at rest (5).”
BackgroundCapaldo, B., Napoli, R., di Marino, L., Guida, R., Pardo, F., & Saccá, L. (1994) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.79.3.8077375 · Cited by 5
Quinones, M. D., & Lemon, P. W. R. (2019) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2018-0217 · Cited by 6
“Furthermore, most sports drinks are composed of simple sugars (sucrose or fructose) or maltodextrin, which are digested and absorbed very rapidly (e.g., have a high glycemic index and reduce exercise fat utilization because of greater circulating insulin; Bonadonna et al., 1990).”
BackgroundDifferential effect of insulin on saturated and unsaturated fatty acids
Townsend, R. R., & Zhao, H. (2002) · Metabolism · doi:10.1053/meta.2002.31344 · Cited by 4
Riemens, S., Dullaart, R., Franssen, E., Piers, D., Reitsma, W., & Sluiter, W. (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00249.x · Cited by 4
Webber, J., Whitelaw, D., Smith, J. M., & Nattrass, M. (1999) · Diabetes, obesity and metabolism · doi:10.1046/j.1463-1326.1999.00011.x · Cited by 3
Snitker, S., Hellmér, J., Boschmann, M., Odeleye, O. E., Monroe, M. B., Young, J. B., & Ravussin, E. (1998) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.83.11.5224 · Cited by 3
Kumar, M., Sharma, S., & Vasudeva, N. (2013) · doi:10.5897/ajpp2013.3603 · Cited by 2
Insulin regulation of muscle glucose metabolism: Role of pre‐receptorial mechanisms
Capaldo, B., & Saccà, L. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110405 · Cited by 1
Sending the Signal: Muscle Glycogen Availability as a Regulator of Training Adaptation
Hawley, J. A. (2017) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-72790-5_4 · Cited by 1
“, the rate of appearance [Ra] of FFA into the systemic circulation), an effect that can persist for up to four hours after a carbohydrate-rich meal (Bonadonna et al. 1990).”
BackgroundKumar, M., Sharma, S., & Vasudeva, N. (2013) · doi:10.5897/ajpp2013.3609
“A rise in plasma insulin concentration of only 5 IU/ml inhibits lipolysis by 50%, whereas a reduction in basal insulin levels result in a marked acceleration of lipolysis (Bonadonna et al., 1990).”
Pathogenesis of Type 2 Diabetes
Cusi, K. J., & DeFronzo, R. A. (2001) · Comprehensive physiology · doi:10.1002/j.2040-4603.2001.tb01483.x
Self-citation
Metadata
- Authors
- Bonadonna, R. C., Groop, L. C., Zych, K., Shank, M., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 1990-11-01
- Volume
- 259
- Issue
- 5
- Pages
- E736-E750
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W1872660062
- Cited by
- 149
- References
- 0
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 3 · 2014: 4 · 2013: 5 · 2012: 1
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AM 24 092, 5r01am024092-06)
- National Center for Research Resources (RR 125)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin, plasma free fatty acids, fatty acid turnover, fatty acid oxidation, lipid oxidation, hepatic glucose production, glucose disposal, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Body Height, Body Weight, Calorimetry, Child, Dose-Response Relationship, Drug, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Kinetics, Liver, Male, Oxidation-Reduction, Reference Values, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
